JAUNDICE FOLLOWING VACCINATION FOR YELLOW FEVER
The laboratories of the International Health Division of the Rockefeller Foundation have been active since 1936 in the development and production of a vaccine which by a single injection provides active immunity of long duration against yellow fever.1 As a result of the war emergency the demand for this vaccine has been so great as to require its production on an unprecedented scale.The distribution of yellow fever vaccine manufactured by the Rockefeller Foundation in New York in 19412 was as follows:Great interest was aroused when it was reported by Army authorities in July that an epidemic of jaundice had developed among troops in the United States and abroad. This epidemic started in March and increased until a total of 28,585 cases was reported in July, when it was brought under control.3Circular letter no. 95 from the Surgeon General's Office4 reported that in this epidemic the clinical course of
GREENE CH. LIVER AND BILIARY TRACT: A REVIEW OF THE LITERATURE FOR 1942. Arch Intern Med (Chic). 1943;71(4):563–578. doi:10.1001/archinte.1943.00210040122013
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: